We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
-16.08%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$1.79B
AUM Growth
-$769M
Cap. Flow
-$325M
Cap. Flow %
-18.19%
Top 10 Hldgs %
13.27%
Holding
993
New
75
Increased
285
Reduced
405
Closed
227

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$22.8M
2
GMED icon
Globus Medical
GMED
+$13.6M
3
MTLS
Materialise
MTLS
+$13.3M
4
ABB
ABB Ltd
ABB
+$13.1M
5
BEAT
BioTelemetry, Inc.
BEAT
+$11.5M

Top Sells

Rank Stock Value
1
ZBRA icon
Zebra Technologies
ZBRA
+$12.4M
2
ISRG icon
Intuitive Surgical
ISRG
+$10.6M
3
XLNX
Xilinx Inc
XLNX
+$9.57M
4
VAR
Varian Medical Systems, Inc.
VAR
+$9.34M
5
ROK icon
Rockwell Automation
ROK
+$8.77M

Sector Composition

Rank Sector Weight
1 Technology 25.01%
2 Healthcare 13.46%
3 Industrials 11.37%
4 Consumer Discretionary 8%
5 Financials 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GPI icon
351
Group 1 Automotive
GPI
$3.18B
$1.34M 0.08%
25,390
-3,555
-12% -$198K
MFC icon
352
Manulife Financial
MFC
$73.5B
$1.34M 0.08%
94,389
-3,561
-4% -$56.5K
APOG icon
353
Apogee Enterprises
APOG
$908M
$1.33M 0.07%
44,696
-6,268
-12% -$225K
GEN icon
354
Gen Digital
GEN
$17.5B
$1.32M 0.07%
69,962
+6,385
+10% +$132K
STAG icon
355
STAG Industrial
STAG
$7.19B
$1.32M 0.07%
53,095
+7,129
+16% +$186K
AMGN icon
356
Amgen
AMGN
$222B
$1.32M 0.07%
6,778
+1,540
+29% +$300K
BIG
357
DELISTED
Big Lots, Inc.
BIG
$1.32M 0.07%
45,637
-16,740
-27% -$651K
WLL
358
DELISTED
Whiting Petroleum Corporation
WLL
$1.31M 0.07%
769
-145
-16% -$373K
MATX icon
359
Matsons
MATX
$6.18B
$1.31M 0.07%
40,858
-5,730
-12% -$212K
SRE icon
360
Sempra
SRE
$54.8B
$1.31M 0.07%
24,176
+2,776
+13% +$158K
CPS icon
361
Cooper-Standard Automotive
CPS
$558M
$1.31M 0.07%
21,027
-2,944
-12% -$238K
BXP icon
362
Boston Properties
BXP
$11.1B
$1.3M 0.07%
11,555
+1,284
+13% +$156K
MANT
363
DELISTED
Mantech International Corp
MANT
$1.3M 0.07%
24,835
-9,817
-28% -$551K
ATRA icon
364
Atara Biotherapeutics
ATRA
$76.1M
$1.29M 0.07%
1,488
-572
-28% -$531K
KN icon
365
Knowles
KN
$3.34B
$1.29M 0.07%
96,904
-13,573
-12% -$199K
MRNA icon
366
Moderna
MRNA
$23.6B
$1.29M 0.07%
+84,390
New +$1.39M
FATE icon
367
Fate Therapeutics
FATE
$326M
$1.28M 0.07%
99,794
-94,906
-49% -$1.32M
VIAB
368
DELISTED
Viacom Inc. Class B
VIAB
$1.28M 0.07%
49,816
+804
+2% +$24.8K
PLXS icon
369
Plexus
PLXS
$7.23B
$1.27M 0.07%
24,940
-3,489
-12% -$196K
PEG icon
370
Public Service Enterprise Group
PEG
$37.7B
$1.26M 0.07%
24,246
+9,406
+63% +$506K
AZO icon
371
AutoZone
AZO
$51.1B
$1.26M 0.07%
1,504
+356
+31% +$285K
DRE
372
DELISTED
Duke Realty Corp.
DRE
$1.26M 0.07%
48,549
+5,525
+13% +$153K
THC icon
373
Tenet Healthcare
THC
$21.1B
$1.25M 0.07%
72,993
-15,493
-18% -$375K
NSIT icon
374
Insight Enterprises
NSIT
$4.38B
$1.24M 0.07%
30,529
-4,281
-12% -$197K
DG icon
375
Dollar General
DG
$27.9B
$1.24M 0.07%
11,459
-2,929
-20% -$317K
13 14
15
16 17

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
WI
Winder Investment Singapore $4.4B AUM 8.87% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return

Vident Investment Advisory's Q4 2018 Portfolio in Review

As of Q4 2018, Vident Investment Advisory held 993 positions worth $1.79B, down 30% from $2.55B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Vident Investment Advisory withdrew a net $325M in Q4 2018, closing 227 positions and reducing 405 holdings. Its most notable exit was Lazard, an estimated $3.82M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Vident Investment Advisory opened a new position in Globus Medical worth $11.8M.

  • Vident Investment Advisory's largest Q4 2018 buy was Globus Medical: 272,897 shares worth $11.8M.
  • Vident Investment Advisory added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $22.8M increase.
  • Vident Investment Advisory's biggest Q4 2018 reduction was Zebra Technologies, cutting an estimated $12.4M.
  • Vident Investment Advisory fully exited Lazard in Q4 2018, selling an estimated $3.82M.
  • Vident Investment Advisory's ten largest holdings make up 13% of its $1.79B portfolio in Q4 2018.
  • Vident Investment Advisory opened 75 new positions and closed 227 in Q4 2018.
  • Vident Investment Advisory's portfolio value fell 30% quarter-over-quarter to $1.79B.

Based on Vident Investment Advisory's 13F filing for Q4 2018, filed 14 Feb 2019.